Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Type 2 Diabetes and Gestational Diabetes Among Women in Kisantu, Democratic Republic of Congo (KIS-Antwerp)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05039307
Recruitment Status : Recruiting
First Posted : September 9, 2021
Last Update Posted : September 9, 2021
Sponsor:
Collaborator:
Memisa, Belgium
Information provided by (Responsible Party):
Institute of Tropical Medicine, Belgium

Brief Summary:
This study aims to develop and implement a long-term program focused on the prevention of type 2 diabetes Mellitus (T2DM) and gestational diabetes mellitus (GDM) in women of reproductive age through lifestyle modification. This is a cluster-randomized trial whereby 6 health centers across Kisantu, Democratic Republic of Congo (DRC) will be randomized to an intervention group (3 health centers) or a comparison group (3 health centers). The intervention group will be provided with a preventive program based on educational + motivational strategies when the comparison group will be limited to an educational strategy only. This study will last 24 months and is limited to women of reproductive age (18-49 years), pregnant and non-pregnant. Evaluation of this research will use mixed longitudinal analyses for healthy lifestyle adherence, anthropometric and clinical indicators, diet quality, and physical activity. Expected results of this study for women of reproductive age include the prevention of T2DM and GDM through the acquisition of healthy lifestyle behavior, reaching and maintaining an optimal weight, blood pressure and glycemia, and adhere to the weight gain recommendations during pregnancy. Other expected achievements encompass improvements in the usability of data capturing systems, expand knowledge among health care providers on effective strategies for T2DM and GDM prevention and improve the technique and precision of measurements concerning health visits among health care providers, among others.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus, Type 2 Gestational Diabetes Behavioral: Educational and motivational strategy Not Applicable

Detailed Description:

Background: As the obesity epidemic continues to rise, it is expected that rates of T2DM and GDM will be also increasing among women in Sub-Saharan Africa (SSA). Women of reproductive age are a particularly vulnerable group, and there is a need for preventive programs addressing the incidence of obesity, T2DM, and GDM.

Objective: This study aims to develop, implement, and evaluate a long-term program (KIS-Antwerp) focused on the prevention of T2DM and GDM in women through a healthy lifestyle promotion.

Methods: The study will take place in 6 healthcare centers across Kisantu, DRC, and will be limited to women of reproductive age (18-49 years) irrespectively of pregnancy status. KIS-Antwerp will be implemented and evaluated using a matched cluster randomized controlled trial where the 6 healthcare will be randomized into an intervention group and a comparison group. The duration of the present study is 24 months. A total of 144 participants per arm is necessary to detect a 12% change in the primary outcome with a level of significance of 0.05, power >80%, and considering a 20% loss of follow-up. The intervention group will be provided with a preventive intervention program based on educational + motivational strategies including the following intervention program components: Individualized education, group education, physical activity sessions, setting goals, and usage of a pedometer. The comparison group will be limited to a basic educational strategy only (basic individual education). Participants will be followed up for 24 months and measurements will be assessed every 6-months period.

Statistical methods: Demographic characteristics will be reported as measures of central tendency for continuous outcomes and frequency distribution and percentages for binary/categorical data. Consequently, demographic data will be explored for differences at baseline by comparing and testing means. After the termination of the study, the primary and secondary outcomes will be evaluated for normality by the Kolmogorov-Simonov test and visual inspection of histograms. For the primary ordinal outcome, the impact of the intervention program between baseline and follow up of the 2 groups (intervention and comparison group) will be assessed by using linear mixed models for repeated measurements.

Safety: This study imposes a low risk for the participants as the intervention program compromises a lifestyle modification through education and motivational strategies and the measurements to be taken are non-invasive, with the exception of blood glucose assessment by blood sampling using a finger prick. For this measurement, guidelines with all the necessary steps and equipment will be followed.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 288 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A cluster randomized controlled trial (cRCT) with a hierarchical design will be conducted whereby 2 groups of 3 healthcare centers (in total 6 healthcare centers) will be randomized to an intervention group or comparison group.
Masking: None (Open Label)
Masking Description: Masking is not possible due to the nature of this research.
Primary Purpose: Prevention
Official Title: Prevention of Type 2 Diabetes and Gestational Diabetes Among Women of Reproductive Age in Kisantu, Democratic Republic of Congo
Actual Study Start Date : August 20, 2021
Estimated Primary Completion Date : October 31, 2023
Estimated Study Completion Date : October 31, 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Healthy Living

Arm Intervention/treatment
Experimental: Intervention group (Educational and motivational strategy)
The intervention group will be provided with a multi-component intervention entailing the following components distributed over the 24-months study: 4 individualized education sessions at the household, 4 group activities (2 group education sessions and 2 physical activity sessions) at the healthcare center, and 4 focus groups at the healthcare center as well. The motivational components of goal setting and the use of a pedometer will be incorporated in the individualized education sessions. Moreover, community activities will be incorporated in the second year of the study after exploring whether the activities are feasible and acceptable by the community. The topics covered by the intervention are healthy diet, physical activity, weight control strategies and knowledge and awareness of T2DM and GDM. Additionally, at baseline participants will be provided with a healthy lifestyle brochure with general recommendations.
Behavioral: Educational and motivational strategy
The intervention will focus on the following topics A) Healthy diet: food pyramid, a healthy plate distribution, type of carbohydrates and fats, healthy cooking techniques and healthy oils. B) Physical activity: definition, types of physical activity, advantages and benefits, examples, active physical activity sessions. C) Weight control: strategies, benefits and healthy weight gain during pregnancy. D) Knowledge and awareness of T2DM and GDM: definition, prevention, management and complications. These topics will be delivered through individualized education, group sessions and focus groups. Participants will be provided with printed material at baseline and also during the individual education sessions at the household containing a brief summary of the topics covered. The motivational components of goal setting and the use of a pedometer will be incorporated explained during the individual education sessions. The intervention will be primarily delivered by trained peer educators.

No Intervention: Comparison group (Basic educational strategy)
The comparison group will be limited to receive the healthy lifestyle brochure with general recommendations at baseline only.



Primary Outcome Measures :
  1. Change from baseline in the adherence to a healthy lifestyle score at 24 months [ Time Frame: Baseline and 24 months ]
    The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.

  2. Change from baseline in the adherence to a healthy lifestyle score at 12 months [ Time Frame: Baseline and 12 months ]
    The adherence to a healthy lifestyle will be measured by using a validated questionnaire for weight control in lifestyle-related diseases that compromise 14 questions, 12 regarding diet and 2 related to physical activity. Each question has 5 multiple choice answers (A, B, C, D, E). This questionnaire provides a final score ranging between 14-65 points. A lower score indicates poor adherence to a healthy lifestyle, while a high score indicates good adherence.


Secondary Outcome Measures :
  1. Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 24 months [ Time Frame: Baseline and 24 months ]
    The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.

  2. Change from baseline in the minimum diet diversity of women (MDD-W) questionnaire at 12 months [ Time Frame: Baseline and 12 months ]
    The MDD-W dichotomous questionnaire developed by the Food and Agriculture Organization of the United Nations (FAO) will be used to measure women's diet diversity.

  3. Change from baseline in the International Physical Activity Questionnaire at 24 months [ Time Frame: Baseline and 24 months ]
    The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.

  4. Change from baseline in the International Physical Activity Questionnaire at 12 months [ Time Frame: Baseline and 12 months ]
    The International Physical activity Questionnaire (IPAQ) short Form will be used to assess the level of physical activity of the participants.

  5. Change from baseline in weight at 24 months [ Time Frame: Baseline and 24 months ]
    Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.

  6. Change from baseline in weight at 12 months [ Time Frame: Baseline and 12 months ]
    Weight will be measured in kg and by using a digital weight scale. The WHO STEPwise guideline will be followed for this measurement.

  7. Change from baseline in Body mass index (BMI) at 24 months [ Time Frame: Baseline and 24 months ]
    BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.

  8. Change from baseline in Body mass index (BMI) at 12 months [ Time Frame: Baseline and 12 months ]
    BMI will be calculated by using the formula BMI= weight in kg/height in meters squared.

  9. Change from baseline in waist circumference at 24 months [ Time Frame: Baseline and 24 months ]
    Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.

  10. Change from baseline in waist circumference at 12 months [ Time Frame: Baseline and 12 months ]
    Waist circumference will be measured in cm and y using a constant tension tape. The WHO STEPwise guideline will be followed for this measurement.

  11. Change from baseline in glycemia at 24 months [ Time Frame: Baseline and 24 months ]
    Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.

  12. Change from baseline in glycemia at 12 months [ Time Frame: Baseline and 12 months ]
    Glycemia will be measured in mg/dL by using by pricking the fingertip with a lancet and glucometer. The WHO STEPwise guideline will be followed for this measurement.

  13. Change from baseline in systolic and diastolic blood pressure at 24 months [ Time Frame: Baseline and 24 months ]
    Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.

  14. Change from baseline in systolic and diastolic blood pressure at 12 months [ Time Frame: Baseline and 12 months ]
    Systolic and diastolic blood pressure will me measured in mm Hg and by using an OMRON. The WHO STEPwise guideline will be followed for this measurement.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 49 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Non-pregnant or (first trimester) pregnant women
  • Women of reproductive age (18-49 years old)
  • Without a previous diagnosis of type 1 diabetes or T2DM (confirmed by a random glucose test)

Exclusion Criteria:

  • Pregnant women with active gestational diabetes
  • Adult males, and children and adolescents <18 years old of both sexes
  • Pre-existent severe chronic conditions (e.g. chronic liver or kidney disease, chronic obstructive pulmonary disease)
  • Living outside of the surrounding catchment areas of the 6 healthcare centers.
  • Women internationally displaced, without a permanent home or identified physical address.
  • Women planning to move elsewhere in the following 2 years
  • Women that do not provide a written Informed Consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05039307


Contacts
Layout table for location contacts
Contact: Diertho Mputu, MD; MPH +243897774940 ed_kembo@yahoo.fr
Contact: Olivier Kidima, MSc +243890357905 oli.kidima@memisa-rdc.org

Locations
Layout table for location information
Congo, The Democratic Republic of the
NKANDU 1 Recruiting
Kisantu, Congo Central, Congo, The Democratic Republic of the
Contact: Diertho Mputu, MSc       ed_kembo@yahoo.fr   
Sponsors and Collaborators
Institute of Tropical Medicine, Belgium
Memisa, Belgium
Investigators
Layout table for investigator information
Principal Investigator: Jean C. Kalobu, MD; MPH Memisa
Principal Investigator: José L. Peñalvo, PhD Institute of Tropical Medicine
Principal Investigator: Diana M. Sagastume, MSc Institute of Tropical Medicine
Layout table for additonal information
Responsible Party: Institute of Tropical Medicine, Belgium
ClinicalTrials.gov Identifier: NCT05039307    
Other Study ID Numbers: 1482/21
First Posted: September 9, 2021    Key Record Dates
Last Update Posted: September 9, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Institute of Tropical Medicine, Belgium:
Prevention
Type 2 diabetes
Gestational diabetes
Women of reproductive age
Healthy lifestyle
Democratic Republic of the Congo
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes, Gestational
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications